RBETX | RFETX | RBETX / RFETX | |
Total Expense Ratio | 1.42 | 0.33 | 430% |
Annual Report Gross Expense Ratio | 1.42 | 0.33 | 430% |
Fund Existence | 19 years | 16 years | - |
Gain YTD | 12.351 | 13.187 | 94% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 250 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 52.2B | 52.2B | 100% |
Annual Yield % from dividends | 1.22 | 2.14 | 57% |
Returns for 1 year | 10.04 | 11.27 | 89% |
Returns for 3 years | 33.23 | 36.77 | 90% |
Returns for 5 years | 25.81 | 31.56 | 82% |
Returns for 10 years | 59.85 | 69.35 | 86% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
HELX | 30.97 | 0.53 | +1.74% |
Franklin Genomic Advancements ETF | |||
RILA | 11.84 | 0.13 | +1.15% |
Indexperts Gorilla Aggressive Growth ETF | |||
PHYL | 35.79 | 0.06 | +0.17% |
PGIM Active High Yield Bond ETF | |||
XOCT | 36.77 | 0.03 | +0.08% |
FT Vest US Eq Enh & Mod Buf ETF-Oct | |||
IBDU | 23.50 | -0.01 | -0.04% |
iShares iBonds Dec 2029 Term Corp ETF |